Boston Scientific Corporation (ETR:BSX)
Germany · Delayed Price · Currency is EUR | Market Cap | 129.87B |
| Revenue (ttm) | 16.49B |
| Net Income (ttm) | 2.38B |
| Shares Out | n/a |
| EPS (ttm) | 1.59 |
| PE Ratio | 54.59 |
| Forward PE | 30.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 128 |
| Average Volume | 508 |
| Open | 87.20 |
| Previous Close | 87.20 |
| Day's Range | 87.20 - 87.80 |
| 52-Week Range | 75.20 - 104.00 |
| Beta | n/a |
| RSI | 54.00 |
| Earnings Date | Feb 5, 2026 |
About Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]
Financial Performance
In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.
Financial numbers in USD Financial StatementsNews
BSX Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investor model based on the published strategy ...
Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Boston Scientific (BSX) Announces 2026 Compensation Plans to Drive Performance and Shareholder Value
Boston Scientific (BSX) Announces 2026 Compensation Plans to Drive Performance and Shareholder Value
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
$100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today
Boston Scientific (NYSE: BSX) has outperformed the market over the past 15 years by 7.62% on an annualized basis producing an average annual return of 19.65%. Currently, Boston Scientific has a marke...
Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
BSX's month-long rally, strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness...
If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.
What's Behind Boston Scientific's Optimism for Urology Growth?
BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.
A Look Into Boston Scientific Inc's Price Over Earnings
In the current session, the stock is trading at $99.67, after a 0.62% increase. Over the past month, Boston Scientific Inc. (NYSE: BSX) stock increased by 3.82% , and in the past year, by 11.95% . Wi...
Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX)
Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX)
Elutia Inc Reports Q3 2025 Revenue of $3. ...
Elutia Inc Reports Q3 2025 Revenue of $3.3 Million, Missing Estimates; Strategic Sale to Boston Scientific Completed
Artisan Global Opportunities Fund Q3 2025 Portfolio Update
During the quarter, we initiated new positions in Spotify, L3Harris Technologies and Insmed. We also added to 3i Group, West Pharmaceutical and Amazon during the quarter. We ended our investment campa...
BSX Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investor model based on the published strategy ...
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)
Boston Scientific announces upcoming investor conference schedule
MARLBOROUGH, Mass. , Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
Demographic Megatrend: Stocks Poised to Benefit From Global Aging
Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.
BSX December 12th Options Begin Trading
Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BS...
Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock.
Ellen Zane Sells Shares of Boston Scientific Corp
Ellen Zane Sells Shares of Boston Scientific Corp
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 5.86% on an annualized basis producing an average annual return of 18.39%. Currently, Boston Scientific has a marke...